The ROE as of December 2024 (TTM) for Frequency Therapeutics, Inc. (FREQ) is -58.14%

According to Frequency Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -58.14%. This represents a change of 296.12% compared to the average of -14.68% of the last 4 quarters.

Frequency Therapeutics, Inc. (FREQ) Historical ROE (quarterly & annually)

How has FREQ ROE performed in the past?

The mean historical ROE of Frequency Therapeutics, Inc. over the last ten years is 20.84%. The current -58.14% ROE has changed -379.05% with respect to the historical average. Over the past ten years (40 quarters), FREQ's ROE was at its highest in in the June 2023 quarter at 7.97%. The ROE was at its lowest in in the March 2023 quarter at -36.70%.

Frequency Therapeutics, Inc. (FREQ) ROE by Quarter and Year

Discovering the peaks and valleys of Frequency Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Frequency Therapeutics, Inc. (FREQ) Average ROE

How has FREQ ROE performed in the past?

The current ROE of Frequency Therapeutics, Inc. (FREQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Frequency Therapeutics, Inc. (FREQ) ROE vs. Peers

How is FREQ’s ROE compared to its peers?

Frequency Therapeutics, Inc.’s ROE is greater than Lineage Cell Therapeutics, Inc. (-29.91%), less than MAIA Biotechnology, Inc. (20.47%), less than Armata Pharmaceuticals, Inc. (89.12%), greater than Portage Biotech Inc. (-673.96%), greater than PMV Pharmaceuticals, Inc. (-24.20%), greater than Olema Pharmaceuticals, Inc. (-53.55%), greater than Enochian Biosciences, Inc. (-73.71%), greater than Scholar Rock Holding Corporation (-145.60%), greater than Passage Bio, Inc. (-72.53%), greater than Shattuck Labs, Inc. (-61.92%), greater than C4 Therapeutics, Inc. (-42.45%), less than Eliem Therapeutics, Inc. (0%), greater than Prelude Therapeutics Incorporated (-66.88%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), less than Absci Corporation (0%), greater than Adverum Biotechnologies, Inc. (-46.56%), greater than Kezar Life Sciences, Inc. (-65.14%), greater than Oncternal Therapeutics, Inc. (-59.73%), greater than null (-177.58%),

Build a custom stock screener for Frequency Therapeutics, Inc. (FREQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Frequency Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Frequency Therapeutics, Inc. (FREQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Frequency Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.